NCT01134328

Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC™ Model

A Multi-Center, Randomized, Double-Masked Evaluation of the Efficacy of Cetirizine 0.1%/Fluticasone 0.005% Ophthalmic Solution Compared to Its Components and Vehicle in a Modified Conjunctival Allergen Challenge (CAC) Model During Pollen Season

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 83 (actual)
• Sponsor: Aciex Therapeutics, Inc. · Industry
• Sex: All
• Age: 10 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the efficacy of AC-150 compared to vehicle and its components in the prevention of the signs and symptoms of allergic conjunctivitis in Enviro-CAC™ Model.

Conditions

• Allergic Conjunctivitis

Interventions

Type	Name	Description
DRUG	AC-150 Combo	1 drop in each eye for up to 14 days
DRUG	AC-150A 0.1%	1 drop in each eye once per day for up to 14 days
DRUG	AC-150B 0.005%	1 drop in each eye once per day for up to 14 days
DRUG	Vehicle	1 drop in each eye once per day for up to 14 days

Timeline

• Start date: 2010-05-01
• Primary completion: 2010-07-01
• Completion: 2010-07-01
• First posted: 2010-06-02
• Last updated: 2017-09-14
• Results posted: 2017-09-14

Locations

1 site across 1 country: United States